Voglic SJ - Search Results

1

Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma.

Aikawa M, Rabkin E, Voglic SJ, Shing H, Nagai R, Schoen FJ, Libby P. Aikawa M, et al. Among authors: voglic sj. Circ Res. 1998 Nov 16;83(10):1015-26. doi: 10.1161/01.res.83.10.1015. Circ Res. 1998. PMID: 9815149

2

Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma.

Aikawa M, Sugiyama S, Hill CC, Voglic SJ, Rabkin E, Fukumoto Y, Schoen FJ, Witztum JL, Libby P. Aikawa M, et al. Among authors: voglic sj. Circulation. 2002 Sep 10;106(11):1390-6. doi: 10.1161/01.cir.0000028465.52694.9b. Circulation. 2002. PMID: 12221058

3

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE, Sukhova GK, Libby P. Aikawa M, et al. Among authors: voglic sj. Circulation. 1998 Jun 23;97(24):2433-44. doi: 10.1161/01.cir.97.24.2433. Circulation. 1998. PMID: 9641696

4

Dietary lipid lowering reduces tissue factor expression in rabbit atheroma.

Aikawa M, Voglic SJ, Sugiyama S, Rabkin E, Taubman MB, Fallon JT, Libby P. Aikawa M, et al. Among authors: voglic sj. Circulation. 1999 Sep 14;100(11):1215-22. doi: 10.1161/01.cir.100.11.1215. Circulation. 1999. PMID: 10484543

5

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro.

Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P. Aikawa M, et al. Among authors: voglic sj. Circulation. 2001 Jan 16;103(2):276-83. doi: 10.1161/01.cir.103.2.276. Circulation. 2001. PMID: 11208689

6

Aspirin (5 mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model.

Voisard R, Fischer R, Osswald M, Voglic S, Baur R, Susa M, Koenig W, Hombach V. Voisard R, et al. Circulation. 2001 Mar 27;103(12):1688-94. doi: 10.1161/01.cir.103.12.1688. Circulation. 2001. PMID: 11273998

7

Leukocyte attack in a 3D human coronary in-vitro model.

Voisard R, Voglic S, Baur R, Susa M, Koenig W, Hombach V. Voisard R, et al. Coron Artery Dis. 2001 Aug;12(5):401-11. doi: 10.1097/00019501-200108000-00010. Coron Artery Dis. 2001. PMID: 11491206

8

Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.

Weiss M, Voglic S, Harms-Schirra B, Lorenz I, Lasch B, Dumon K, Gross-Weege W, Schneider EM. Weiss M, et al. Intensive Care Med. 2003 Jun;29(6):904-914. doi: 10.1007/s00134-003-1734-y. Epub 2003 Apr 8. Intensive Care Med. 2003. PMID: 12682721 Clinical Trial.

9

Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study.

Meierhenrich R, Steinhilber E, Eggermann C, Weiss M, Voglic S, Bögelein D, Gauss A, Georgieff M, Stahl W. Meierhenrich R, et al. Crit Care. 2010;14(3):R108. doi: 10.1186/cc9057. Epub 2010 Jun 10. Crit Care. 2010. PMID: 20537138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page